“Efficacy and Safety of FMX103 (1.5% Minocycline Foam) in the Treatment of Moderate to Severe Papulopustular Rosacea: Results from two Phase 3 Randomized, Multicenter, Double Blind, Vehicle Controlled Studies” (2019) SKIN The Journal of Cutaneous Medicine, 3(2), p. 161. doi:10.25251/skin.3.2.1.